UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tardive dystonia induced by atypical neuroleptics: a case report with olanzapine

Journal of child and adolescent psychopharmacology, 2004-03, Vol.14 (1), p.149-152

2004

Volltextzugriff (PDF)

Predictors of medical events in patients enrolled in the cardiac insufficiency bisoprolol study (CIBIS): A study of the interactions between β-blocker therapy and occurrence of critical events using analysis of competitive risks

The American heart journal, 2000-02, Vol.139 (2), p.262-271

2000

Volltextzugriff (PDF)

Effets indésirables, pharmacovigilance

EMC - Traité de médecine AKOS, 2006-01, Vol.1 (1), p.1-4

2006

Volltextzugriff (PDF)

Interactions médicamenteuses en pratique quotidienne

EMC - Traité de médecine AKOS, 2006-01, Vol.1 (1), p.1-3

2006

Volltextzugriff (PDF)

Pharmacocinétique et métabolisme des médicaments

EMC - Traité de médecine AKOS, 2006-01, Vol.1 (1), p.1-6

2006

Volltextzugriff (PDF)

Iatrogenic disease

La revue du praticien, 2005-01, Vol.55 (2), p.209

2005

Volltextzugriff (PDF)

Xenopus Polycomblike 2 ( XPcl2 ) controls anterior to posterior patterning of the neural tissue

Development genes and evolution, 2001-06, Vol.211 (6), p.309-314

2001

Volltextzugriff (PDF)

Drug-associated psychiatric disturbances in medical inpatients

Psychopharmacology, 1981-01, Vol.74 (2), p.105-108

1981

Volltextzugriff (PDF)

Anxiolytic- and Antidepressant-like Effects of the Non-Peptide Vasopressin V1b Receptor Antagonist, SSR149415, Suggest an Innovative Approach for the Treatment of Stress-Related Disorders

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (9), p.6370-6375

2002

Volltextzugriff (PDF)

Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders

Current pharmaceutical design, 2005-05, Vol.11 (12), p.1549-1559

2005

Volltextzugriff (PDF)

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V 1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (9), p.6370-6375

2002

Volltextzugriff (PDF)

Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist

The Journal of pharmacology and experimental therapeutics, 2002-03, Vol.300 (3), p.1122

2002

Volltextzugriff (PDF)

SSR240612 [(2 R )-2-[((3 R )-3-(1,3-Benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2 R ,6 S )-2,6-dimethylpiperidinyl]methyl}phenyl)- N -isopropyl- N -methylpropanamide Hydrochloride], a New Nonpeptide Antagonist of the Bradykinin B 1 Receptor: Biochemical and Pharmacological Characterization

The Journal of pharmacology and experimental therapeutics, 2004-05, Vol.309 (2), p.661-669

2004

Volltextzugriff (PDF)

SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization

The Journal of pharmacology and experimental therapeutics, 2004-05, Vol.309 (2), p.661

2004

Volltextzugriff (PDF)

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization

The Journal of pharmacology and experimental therapeutics, 2002-04, Vol.301 (1), p.322

2002

Volltextzugriff (PDF)

Characterization of (2 S ,4 R )-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H -indol-3-yl]-4-hydroxy- N , N -dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V 1b Receptor Antagonist

The Journal of pharmacology and experimental therapeutics, 2002-03, Vol.300 (3), p.1122-1130

2002

Volltextzugriff (PDF)

Benzodiazepines reduce the tolerance to reward delay in rats

Psychopharmacologia, 1985-01, Vol.86 (1-2), p.147-152

1985

Volltextzugriff (PDF)

4-(2-Chloro-4-methoxy-5-methylphenyl)- N -[(1 S )-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl- N -(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor 1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization

The Journal of pharmacology and experimental therapeutics, 2002-04, Vol.301 (1), p.322-332

2002

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(7)

Publikationsform

Artikel
(17)
magazinearticle
(1)

Sprache

Englisch
(16)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(8)
Male
(7)
Science & Technology
(7)
Animals
(6)
Life Sciences & Biomedicine
(6)
Rats
(6)
Pharmacology & Pharmacy
(5)
Anti-Anxiety Agents - Pharmacology
(3)
Antidiuretic Hormone Receptor Antagonists
(3)
Cho Cells
(3)
Cricetinae
(3)
Mice
(3)
Psychiatry
(3)
Rats, Sprague-Dawley
(3)
Adrenocorticotropic Hormone - Metabolism
(2)
Antidepressive Agents - Pharmacology
(2)
Anxiety
(2)
Anxiety - Drug Therapy
(2)
Behavior, Animal - Drug Effects
(2)
Biological And Medical Sciences
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tardive dystonia induced by atypical neuroleptics: a case report with olanzapine

Predictors of medical events in patients enrolled in the cardiac insufficiency bisoprolol study (CIBIS): A study of the interactions between β-blocker therapy and occurrence of critical events using analysis of competitive risks

Effets indésirables, pharmacovigilance

Interactions médicamenteuses en pratique quotidienne

Pharmacocinétique et métabolisme des médicaments

Iatrogenic disease

Xenopus Polycomblike 2 ( XPcl2 ) controls anterior to posterior patterning of the neural tissue

Drug-associated psychiatric disturbances in medical inpatients

Anxiolytic- and Antidepressant-like Effects of the Non-Peptide Vasopressin V1b Receptor Antagonist, SSR149415, Suggest an Innovative Approach for the Treatment of Stress-Related Disorders

Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V 1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization

Characterization of (2 S ,4 R )-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H -indol-3-yl]-4-hydroxy- N , N -dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V 1b Receptor Antagonist

Benzodiazepines reduce the tolerance to reward delay in rats

4-(2-Chloro-4-methoxy-5-methylphenyl)- N -[(1 S )-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl- N -(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor 1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization

Suchergebnisse filtern